Investigating a universal vaccine for influenza
NIAID Centers of Excellence for Influenza Research and Response: Universal Influenza Vaccine Research Activities
This study is looking at how the flu virus changes and spreads, and how our immune system responds to it, so we can find ways to make better vaccines that protect us longer and work for more types of flu.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-11144908 on NIH RePORTER |
What this research studies
This research focuses on understanding the factors that influence the evolution and transmission of influenza viruses, as well as the immune response to these infections. By conducting cohort studies and sampling from both humans and animals, the research aims to identify key immunological factors that can lead to better protection against influenza. The goal is to improve vaccination strategies and develop a universal influenza vaccine that provides broader and longer-lasting immunity.
Who could benefit from this research
Good fit: Ideal candidates for participation include individuals who are at risk for influenza infection, such as those with underlying health conditions or those in close contact with high-risk populations.
Not a fit: Patients who are not at risk for influenza or those who have already received a recent influenza vaccination may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of a universal influenza vaccine that protects against multiple strains of the virus.
How similar studies have performed: Previous research has shown promise in understanding immune responses to influenza, but this approach aims to develop a novel universal vaccine, making it a significant advancement in the field.
Where this research is happening
Baltimore, United States
- Johns Hopkins University — Baltimore, United States (Active)
Researchers
- Principal investigator: Pekosz, Andrew — Johns Hopkins University
- Study coordinator: Pekosz, Andrew
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.